Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value
$349.38−0.50 (-0.14%)
Close on Nov 12, 2026Market cap $66.67BP/E 25.9Yield 0.63%
Cencora cash
Cash and short-term investments held at the end of each period.
Cencora's cash was $2.82B at Jun 30, 2026. For fiscal 2025 it was $4.36B, up 39.1% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $4.60B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.36B | +39.1% |
| FY2024 | Sep 30, 2024 | $3.13B | +20.9% |
| FY2023 | Sep 30, 2023 | $2.59B | -23.5% |
| FY2022 | Sep 30, 2022 | $3.39B | +33.0% |
| FY2021 | Sep 30, 2021 | $2.55B | -44.6% |
| FY2020 | Sep 30, 2020 | $4.60B | +36.3% |
| FY2019 | Sep 30, 2019 | $3.37B | +35.4% |
| FY2018 | Sep 30, 2018 | $2.49B | +2.4% |
| FY2017 | Sep 30, 2017 | $2.44B | -11.2% |
| FY2016 | Sep 30, 2016 | $2.74B | +26.5% |
| FY2015 | Sep 30, 2015 | $2.17B | +19.8% |
| FY2014 | Sep 30, 2014 | $1.81B | +46.9% |
| FY2013 | Sep 30, 2013 | $1.23B | +15.4% |
| FY2012 | Sep 30, 2012 | $1.07B | -41.6% |
| FY2011 | Sep 30, 2011 | $1.83B | +10.1% |
| FY2010 | Sep 30, 2010 | $1.66B | +64.3% |
| FY2009 | Sep 30, 2009 | $1.01B | +14.9% |
| FY2008 | Sep 30, 2008 | $878.11M | +37.2% |
| FY2007 | Sep 30, 2007 | $640.20M | -49.2% |
| FY2006 | Sep 30, 2006 | $1.26B | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $2.82B | +26.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $2.18B | +10.0% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $1.75B | -45.6% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $4.36B | +39.1% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $2.23B | -32.5% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $1.98B | -4.4% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $3.22B | +12.3% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $3.13B | +20.9% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $3.31B | +138.0% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $2.07B | +34.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $2.87B | +69.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $2.59B | -23.5% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $1.39B | -54.2% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $1.54B | -48.0% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $1.69B | -46.6% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $3.39B | +33.0% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $3.03B | +18.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $2.96B | -55.4% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $3.17B | -35.2% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $2.55B | -44.6% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $2.55B | -25.4% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $6.64B | +79.9% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $4.89B | +51.3% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.60B | +36.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $3.42B | +14.0% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $3.69B | +28.4% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $3.23B | +27.3% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $3.37B | +35.4% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $3.00B | +25.6% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $2.88B | +37.5% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $2.54B | -16.4% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $2.49B | +2.4% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $2.39B | +82.2% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $2.09B | -13.0% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $3.04B | +69.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $2.44B | -11.2% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $1.31B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $2.40B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $1.79B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $2.74B | – |
See a number that looks wrong?